| Primary |
| Parkinson's Disease |
75.6% |
| Drug Effect Decreased |
9.4% |
| Constipation |
2.3% |
| Depression |
2.3% |
| Asthma |
1.8% |
| Hypertension |
1.5% |
| Insomnia |
1.1% |
| Psychotic Disorder |
1.0% |
| Cardiac Failure Chronic |
0.8% |
| Diabetes Mellitus |
0.7% |
| Anxiety |
0.6% |
| Suicide Attempt |
0.5% |
| Osteoporosis |
0.4% |
| Abdominal Discomfort |
0.4% |
| Hypoaesthesia |
0.4% |
| Angina Pectoris |
0.3% |
| Coronary Artery Stenosis |
0.3% |
| Dementia Alzheimer's Type |
0.3% |
| Back Pain |
0.3% |
| Benign Prostatic Hyperplasia |
0.3% |
|
| Hallucination |
10.4% |
| Tremor |
9.4% |
| Death |
6.3% |
| Weight Decreased |
6.3% |
| Somnolence |
5.9% |
| Sudden Onset Of Sleep |
5.9% |
| Wrong Technique In Drug Usage Process |
5.9% |
| Hallucination, Visual |
5.2% |
| Parkinson's Disease |
4.9% |
| Shock |
4.9% |
| Dysphagia |
4.5% |
| Pyrexia |
4.2% |
| White Blood Cell Count Decreased |
4.2% |
| Hepatic Function Abnormal |
3.8% |
| Fall |
3.1% |
| Neuroleptic Malignant Syndrome |
3.1% |
| Psychiatric Symptom |
3.1% |
| Tachycardia |
3.1% |
| White Blood Cell Count Increased |
3.1% |
| Completed Suicide |
2.8% |
|
| Secondary |
| Parkinson's Disease |
58.5% |
| Drug Use For Unknown Indication |
8.1% |
| Drug Effect Decreased |
6.0% |
| Product Used For Unknown Indication |
5.1% |
| Constipation |
2.9% |
| Asthma |
2.5% |
| Hypertension |
2.5% |
| Psychotic Disorder |
2.2% |
| Insomnia |
2.0% |
| Depression |
1.7% |
| Anxiety |
1.4% |
| Dyskinesia |
1.0% |
| Abdominal Discomfort |
0.9% |
| Benign Prostatic Hyperplasia |
0.9% |
| Gastritis |
0.9% |
| Hallucination |
0.8% |
| Anxiety Disorder |
0.7% |
| Osteoporosis |
0.7% |
| Agitation |
0.6% |
| Back Pain |
0.6% |
|
| Poriomania |
8.1% |
| X-ray Gastrointestinal Tract Abnormal |
8.1% |
| Malaise |
6.7% |
| Pulmonary Embolism |
6.0% |
| Tremor |
6.0% |
| Vomiting |
6.0% |
| Cerebral Haematoma |
5.4% |
| Hallucination |
5.4% |
| Parkinson's Disease |
5.4% |
| Pyrexia |
5.4% |
| Somnolence |
5.4% |
| Psychiatric Symptom |
4.7% |
| Red Blood Cell Count Decreased |
4.7% |
| Restlessness |
4.7% |
| Ventricular Hypertrophy |
4.7% |
| Fall |
2.7% |
| Hallucination, Visual |
2.7% |
| Muscle Spasms |
2.7% |
| Nail Discolouration |
2.7% |
| Overdose |
2.7% |
|
| Concomitant |
| Parkinson's Disease |
60.1% |
| Product Used For Unknown Indication |
7.3% |
| Depression |
6.7% |
| Pain |
3.2% |
| Anxiety |
3.2% |
| Constipation |
2.9% |
| Insomnia |
2.7% |
| Hypertension |
1.9% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Back Pain |
1.8% |
| Arthritis |
1.4% |
| Osteoporosis |
1.2% |
| Dementia |
0.9% |
| Drug Use For Unknown Indication |
0.8% |
| Nausea |
0.8% |
| Blood Cholesterol Increased |
0.7% |
| Psychotic Disorder |
0.7% |
| Muscle Spasms |
0.6% |
| Haemorrhoids |
0.5% |
| Type 2 Diabetes Mellitus |
0.5% |
|
| Pathological Gambling |
16.1% |
| Parkinson's Disease |
9.2% |
| Suicidal Ideation |
7.6% |
| Somnolence |
7.2% |
| Sudden Onset Of Sleep |
6.8% |
| Death |
5.2% |
| Weight Decreased |
5.2% |
| Weight Increased |
4.4% |
| Hallucination |
4.0% |
| Stress |
4.0% |
| Suicide Attempt |
4.0% |
| Vomiting |
4.0% |
| Psychotic Disorder |
3.6% |
| Tremor |
3.6% |
| Pharmaceutical Product Complaint |
3.2% |
| Syncope |
2.8% |
| Electrocardiogram Qt Prolonged |
2.4% |
| Pain |
2.4% |
| Asthenia |
2.0% |
| Drug Ineffective |
2.0% |
|
| Interacting |
| Parkinson's Disease |
41.4% |
| Drug Effect Decreased |
26.3% |
| Diabetes Mellitus |
8.1% |
| Pain |
5.1% |
| Thrombosis |
4.0% |
| Constipation |
3.0% |
| Gastritis |
3.0% |
| Hypertension |
3.0% |
| Anxiety |
2.0% |
| Depression |
2.0% |
| Blood Pressure |
1.0% |
| Cardiac Disorder |
1.0% |
|
| Nausea |
21.1% |
| Therapeutic Response Increased |
21.1% |
| Unresponsive To Stimuli |
15.8% |
| Restlessness |
10.5% |
| White Blood Cell Count Decreased |
10.5% |
| Feeling Abnormal |
5.3% |
| Feeling Hot |
5.3% |
| Incorrect Drug Administration Rate |
5.3% |
| Surgery |
5.3% |
|
